Clinical Trial: A Randomized, Double-Blind, Controlled Trial to Assess the Efficacy of a Fortetropin Supplement in Improving Symptoms of Osteoarthritis
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Osteoarthritis
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Controlled Trial to Assess the Efficacy of a Fortetropin Supplement in Improving Symptoms of Osteoarthritis
Brief Summary:
This is a hybrid, double-blind, randomized, placebo-controlled clinical trial that will last 12 weeks.Participants will be randomized into either the intervention product or control group and will consume the test product or control daily.Participants will complete study-specific and validated questionnaires at Baseline, Week 6, and Week 12, as well as blood biomarker testing for a lipid panel and high-sensitivity C-reactive protein (hs-CRP) at Baseline and Week 12.Osteoarthritis-like symptoms, such as joint pain,…
Read more